BIOLASE : Failure to Satisfy Listing Rule - Form 8-K
May 17, 2024 at 06:47 am
Share
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On May 14, 2024, BIOLASE, Inc. (the "Company") received an additional staff determination letter from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC notifying the Company that because its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 that was filed with the U.S. Securities and Exchange Commission on May 13, 2024 reported stockholders' equity of ($1,934,000) as of March 31, 2024, the Company does not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b). As a result, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market and will be considered by the Nasdaq Hearings Panel (the "Panel") in rendering a determination regarding the Company's continued listing on The Nasdaq Capital Market. The Company requested a hearing before the Panel and was granted a hearing date in June 2024.
Attachments
Original Link
Permalink
Disclaimer
BioLase Inc. published this content on
17 May 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
17 May 2024 10:46:03 UTC.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
BIOLASE, INC. 
